Drug Shortage Report for MAVIK
Report ID | 103121 |
Drug Identification Number | 02239267 |
Brand name | MAVIK |
Common or Proper name | TRANDOLAPRIL |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TRANDOLAPRIL |
Strength(s) | 4MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-01-06 |
Estimated end date | 2020-02-25 |
Actual end date | 2020-03-03 |
Shortage status | Resolved |
Updated date | 2020-03-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-03-04 | English | Compare |
v8 | 2020-03-03 | French | Compare |
v7 | 2020-03-03 | English | Compare |
v6 | 2020-02-12 | French | Compare |
v5 | 2020-02-12 | English | Compare |
v4 | 2020-01-21 | French | Compare |
v3 | 2020-01-21 | English | Compare |
v2 | 2020-01-13 | French | Compare |
v1 | 2020-01-13 | English | Compare |
Showing 1 to 9 of 9